Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rosie Lemons"'
Autor:
Carl Koschmann, Soyeon Roh, Felipe J Nunez, Daniel Thomas, Marta Dzaman, David O. Ferguson, Rosie Lemons, Pedro R. Lowenstein, Maria G. Castro, Neha Kamran, Alexandra Calinescu, Flor M. Mendez, Johnny Krasinkiewicz
Publikováno v:
Cancer Research. 75:3009-3009
Pediatric Glioblastoma (GBM) remains one of the most difficult childhood tumors to treat, and most children with this diagnosis will not survive longer than two years. ATRX is a histone chaperone protein that is mutated primarily in pediatric patient
Autor:
Neha Kamran, David O. Ferguson, Carl Koschmann, Vera Gorbunova, Soyeon Roh, Felipe J Nunez, Alan K. Meeker, Marta Dzaman, Johnny Krasinkiewicz, Youping Li, Daniel Thomas, Pedro R. Lowenstein, Rosie Lemons, Maria G. Castro, Lili Zhao, Alexandra Calinescu, Flor M. Mendez
Publikováno v:
Neuro-Oncology. 17:iii10-iii11
Pediatric glioblastoma (GBM) remains one of the most difficult childhood tumors to treat. ATRX is a histone chaperone protein that is mutated primarily in pediatric patients with GBM and younger adults with secondary GBM. No previous animal model has
Autor:
Pedro R. Lowenstein, Daniel Thomas, Alexandra Calinescu, Rosie Lemons, Marta Dzaman, Maria G. Castro, Carl Koschmann
Publikováno v:
Cancer Research. 74:995-995
Pediatric glioblastoma (GBM) remains one of the most difficult childhood tumors to treat, and most patients will die within the first two years of receiving this diagnosis. ATRX is a histone chaperone protein that is mutated primarily in adolescent G
Autor:
Carl Koschmann, Pedro R. Lowenstein, Neha Kamran, Felipe Nunez-Aguilera, Maria G. Castro, Haeji Roh, Daniel Thomas, Rosie Lemons, Youping Li, Marta Dzaman, Alexandra Calinescu
Publikováno v:
Neuro-Oncology. 16:v170-v170
Pediatric glioblastoma (GBM) remains one of the most difficult childhood tumors to treat. ATRX is a histone chaperone protein that is mutated primarily in younger patients with GBM. No previous animal model has demonstrated the effect of ATRX loss on